Navigation Links
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles
Date:9/18/2013

BLUE BELL, Pa., Sept. 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will be presenting an overview of the company at the Aegis Capital Corp. Healthcare Conference and BioCentury's 20th Annual NewsMakers in the Biotech Industry Conference. He will also be the invited speaker at the Town Hall Los Angeles meeting on Tuesday, September 24, 2013. In his speech titled, "Are We Prepared for the Next Pandemic Flu Virus? Is a New Universal Vaccine the Answer," Dr. Kim will discuss the potential devastating effects of an influenza pandemic and how medicine is working urgently to meet the next pandemic.

Aegis Capital Corp. Healthcare Conference

September 25-28, 2013
The Encore at Wynn Las Vegas
Las Vegas, NV

Inovio Presentation
Thursday, September 26, 2013
8:30 AM PT

BioCentury's 20th Annual NewsMakers in the Biotech Industry Conference

September 27, 2013
Millennium Broadway Hotel
New York, NY

Inovio Presentation
Friday, September 27, 2013
11:30 AM ET

A live and archived webcast of the NewsMakers presentation will be accessible on the homepage of Inovio's website under the webcast tab at www.inovio.com.

Town Hall Los Angeles

September 24, 2013
11:30 AM -1:30 PM PT
Millennium Biltmore Hotel
Los Angeles, CA

Individuals interested in attending may register online.

About Town Hall Los Angeles
Town Hall Los Angeles is recognized as one of the Top 10 Executive Leadership Forums. They invite one compelling and newsworthy
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015   KaloBios Pharmaceuticals, Inc . (Nasdaq: ... innovative therapies to benefit patients with diseases of unmet ... that the U.S. Food and Drug Administration (FDA) has ... KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with ... now active. The acceptance of this IND ...
(Date:7/29/2015)... 27, 2015 Research and Markets ( http://www.researchandmarkets.com/research/sxwk89/3d_metrology ... Metrology Market by Product (CMM, ODS, and VMM), Application ... Geography (North America, Europe, APAC, RoW) - Global Forecast ... The 3D metrology market was valued at ... at a rate of 7.11% during the forecast period. ...
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Global 3D Metrology Market 2015-2020: Products (CMM, ODS, and VMM) & Applications (Automotive, Aerospace, Energy & Power, Medical and Electronics) 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...
... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...
Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3
(Date:7/29/2015)... ... July 29, 2015 , ... The power ... crowd-funding campaigns that give small businesses financial support, social connections can be used ... in employee health management programs, unveiled today a downloadable resource for employers that ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... have become increasingly aware of the impact drinking and substance abuse is having ... illness. Financial loss is tagged in the billions per year. [1] Will Wesch, ...
(Date:7/29/2015)... ... 29, 2015 , ... Gender minority people who are transgender ... has provided legal protections against discrimination on the basis of gender identity in ... discrimination based on gender identity in places open to the public, such as ...
(Date:7/29/2015)... Miami, FL (PRWEB) , ... July 29, 2015 , ... ... in states where marijuana is legal, and are exposed to advertisements, for medicinal use ... University revealed teenagers in settings where the use of marijuana is considered beneficial are ...
(Date:7/29/2015)... ... 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates ... Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil ... by Potomac Pilates will continue to offer the same classes and personal experiences their ...
Breaking Medicine News(10 mins):Health News:StayWell Unveils Employer Guide to Developing Effective Employee Wellness Champion Networks 2Health News:StayWell Unveils Employer Guide to Developing Effective Employee Wellness Champion Networks 3Health News:StayWell Unveils Employer Guide to Developing Effective Employee Wellness Champion Networks 4Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2
... new study to asses patient awareness of medications prescribed during ... a medication they were not, and 96% were unable to ... had been prescribed during hospitalization. These findings are published ... Inpatient medication errors represent an important patient safety issue, with ...
... , , WARRINGTON, Pa., Dec. 9 ... from nearly 600 applicants to receive part of $25,000 in PR ... it gives all of us here a warm and fuzzy feeling ... worthwhile causes," said Neotrope CEO and co-founder, Christopher L. Simmons. "We ...
... RIO DE JANEIRO, Dec. 9 Amilpar ... AMIL3.SA), the largest managed,care organization in Brazil, in addition to ... 2009, informs its shareholders and the,market that the initiatives to ... as Applicant its subsidiary AMIL ASSISTENCIA MEDICA,INTERNACIONAL LTDA. The filing ...
... Dec. 9 Kendall-Jackson Winery today sent a check ... concluding its five-month-long, online auction of items donated by ... Rachel Alexandra,s historic 2009 racing season. New items were ... item was the final lot: a visit with Rachel ...
... last year, survey shows , WEDNESDAY, Dec. 9 (HealthDay News) -- ... flu in general, there has been only a slight increase in ... a new report shows. , By the middle of November, only ... had gotten a shot, according to the survey. Seasonal flu vaccine ...
... The Michigan Minority Business Development Council (MMBDC) announced ... 29 at the Detroit Symphony Orchestra/Max Fisher Music Center, MMBDC ... for this year,s awards was: "Celebrating the Stars of ... individuals who actively include certified minority suppliers in their procurement ...
Cached Medicine News:Health News:Study highlights lack of patient knowledge regarding hospital medications 2Health News:Nonprofit Partners With PR Company and Gains International Attention 2Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2Health News:Seasonal Flu Vaccination Rates Still Too Low 2Health News:Seasonal Flu Vaccination Rates Still Too Low 3Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2
... Examination Tables deliver the highest quality care to ... types of patients can face a frustrating dilemma ... the exam table. Being able to easily get ... comfort during the exam, help the physician conduct ...
... This site introduces the DiamondTome™ ... with its unique DiamondTome™ Wands, an ... better way to smoother, more youthful ... we present the benefits of DiamondTome's™ ...
... Expand your practice with the advantages of ... effective treatment of leg veins and other deeper ... and fast. As a stand alone device or ... the Quantum DL treats a range of conditions ...
Inquire...
Medicine Products: